本章参考文献
［1］Feinberg，A.P.Phenotypic plasticity and the epigenetics of human disease［J］.Nature，2007，447：433－440.
［2］Kornberg，R.D.and Lorch，Y.Twenty-five years of the nucleosome，fundamental particle of the eukaryote chromosome［J］.Cell，1999，98（3）：285－294.
［3］Quina，A.S.，Buschbeck，M.and DiCroce，L.Chromatin structure and epigenetics［J］.Biochem Pharmacol，2006，72（11）：1563－1569.
［4］Strahl，B.D.and Allis，C.D.The language of covalent histone modifications［J］.Nature，2000，403：41－45.
［5］An，W.Histone acetylation andmethylation：Combinatorial players for transcriptional regulation［J］.Subcell Biochem，2007，41：351－369.
［6］Gregoretti，I.V.，Lee，Y.M.and Goodson，H.V.Molecular evolution of the histone deacetylase family：Functional implications of phylogenetic analysis［J］.JMol Biol，2004，338（1）：17－31.
［7］Xu，W.S.，Parmigiani，R.B.and Marks，P.A.Histone deacetylase inhibitors：Molecularmechanisms of action［J］.Oncogene，2007，26（37）：5541－5552.
［8］Adcock，I.M.，Ford，P.，Ito，K.，et al.Epigenetics and airways disease［J］.Respir Res，2006，7：21.
［9］Hildmann，C.，Riester，D.and Schwienhorst，A.Histone deacetylases—an important class of cellular regulators with a variety of functions［J］.Appl Microbiol Biotechnol，2007，75（3）：487－497.
［10］Morera，L.，Lubbert，M.and Jung，M.Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy［J］.Clin Epigenetics，2016，8：57.
［11］Banerjee，T.and Chakravarti，D.A peek into the complex realm of histone phosphorylation［J］.Mol Cell Biol，2011，31（24）：4858－4873.
［12］Fuchs，G.and Oren，M.Writing and reading H2B monoubiquitylation［J］.Biochim Biophys Acta，2014，1839（8）：694－701.
［13］Wang，H.，Wang，L.，Erdjument-Bromage，H.，et al.Role of histone H2A ubiquitination in Polycomb silencing［J］.Nature，2004，431：873－878.
［14］Lee，R.C.，Feinbaum，R.L.and Ambros，V.The C.elegans heterochronic gene lin-4 encodes small RNAswith antisense complementarity to lin-14［J］.Cell，1993，75（5）：843－854.
［15］Lagos-Quintana，M.，Rauhut，R.，Lendeckel，W.，et al.Identification of novel genes coding for small expressed RNAs［J］.Science，2001，294：853－858.
［16］Fang，Y.and Fullwood，M.J.Roles，functions，andmechanisms of long non-coding RNAs in cancer［J］.Genomics Proteomics Bioinformatics，2016，14（1）：42－54.
［17］Potok，M.E.，Nix，D.A.，Parnell，T.J.，et al.Reprogramming the maternal zebrafish genome after fertilization to match the paternal methylation pattern［J］.Cell，2013，153（4）：759－772.
［18］Jiang，L.，Zhang，J.，Wang，J.J.，et al.Sperm，but not oocyte，DNA methylome is inherited by zebrafish early embryos［J］.Cell，2013，153（4）：773－784.
［19］Perkins，D.O.，Jeffries，C.and Sullivan，P.Expanding the“central dogma”：The regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia［J］.Mol Psychiatry，2005，10（1）：69－78.
［20］Gottesman，I.I.and Wolfgram，D.L.Schizophrenia Genesis：TheOriginsofMadness［M］.New York：WH Freeman，1991.
［21］Impagnatiello，F.，Guidotti，A.R.，Pesold，C.，et al.A decrease of reelin expression as a putative vulnerability factor in schizophrenia［J］.Proc Natl Acad Sci USA，1998，95（26）：15718－15723.
［22］Chen，Y.，Sharma，R.P.，Costa，R.H.，et al.On the epigenetic regulation of the human reelin promoter［J］.Nucleic Acids Res，2002，30（13）：2930－2939.
［23］Niwa，M.，Jaaro-Peled，H.，Tankou，S.，et al.Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids［J］.Science，2013，339：335－339.
［24］曾真.DGKH、FGFR2基因在精神分裂症、双向情感障碍和重度抑郁症中的共享风险分析及NOS3基因与糖尿病肾病的荟萃分析［D］.上海：上海交通大学，2010.
［25］Gavin，D.P.and Akbarian，S.Epigenetic and post-transcriptional dysregulation of gene expression in schizophrenia and related disease［J］.Neurobiol Dis，2012，46（2）：255－262.
［26］Robertson，K.D.DNA methylation and human disease［J］.Nat Rev Genet，2005，6（8）：597－610.
［27］Robertson，K.D.and Wolffe，A.P.DNA methylation in health and disease［J］.Nat Rev Genet，2000，1（1）：11－19.
［28］Schanen，N.C.Epigenetics of autism spectrum disorders［J］.Hum Mol Genet，2006，2：R138－R150.
［29］Tsankova，N.，Renthal，W.，Kumar，A.，et al.Epigenetic regulation in psychiatric disorders［J］.Nat Rev Neurosci，2007，8（5）：355－367.
［30］Herrera，A.S.，Casanova，J.P.，Gatica，R.I.，et al.Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization［J］.Prog Neuropsychopharmacol Biol Psychiatry，2013，47：1－6.
［31］Valenti，O.，Cifelli，P.，Gill，K.M.，et al.Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental ratmodel of schizophrenia［J］.JNeurosci，2011，31（34）：12330－12338.
［32］Boley，A.M.，Perez，S.M.and Lodge，D.J.A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia［J］.Schizophr Res，2014，157（1－3）：238－243.
［33］Gilani，A.I.，Chohan，M.O.，Inan，M.，et al.Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in amousemodel of hippocampal disinhibition［J］.Proc Natl Acad Sci USA，2014，111（20）：7450－7455.
［34］Salavati，B.，Rajji，T.K.，Price，R.，et al.Imaging-based neurochemistry in schizophrenia：A systematic review and implications for dysfunctional long-term potentiation［J］.Schizophr Bull，2015，41（1）：44－56.
［35］Seeman，P.Dopamine D2 receptors as treatment targets in schizophrenia［J］.Clin Schizophr Relat Psychoses，2010，4（1）：56－73.
［36］Cole，D.M.，Oei，N.Y.，Soeter，R.P.，et al.Dopamine-dependent architecture of cortico-subcortical network connectivity［J］.Cereb Cortex，2013，23（7）：1509－1516.
［37］Tan，H.Y.，Callicott，J.H.and Weinberger，D.R.Dysfunctional and compensatory prefrontal cortical systems，genes and the pathogenesis of schizophrenia［J］.Cereb Cortex，2007，17 Suppl1：i171－i181.
［38］Gogos，J.A.and Gerber，D.J.Schizophrenia susceptibility genes：Emergence of positional candidates and future directions［J］.Trends Pharmacol Sci，2006，27（4）：226－233.
［39］Cross-Disorder Group of the Psychiatric Genomics Consortium.Identification of risk lociwith shared effects on fivemajor psychiatric disorders：A genome-wide analysis［J］.Lancet，2013，381：1371－1379.
［40］Craddock，N.and Sklar，P.Genetics of bipolar disorder［J］.Lancet，2013，381：1654－1662.
［41］Ceaser，A.，Csernansky，J.G.and Barch，D.M.COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individualswith schizophrenia，their siblings，and healthy controls［J］.Cogn Neuropsychiatry，2013，18（4）：257－283.
［42］Tan，H.Y.，Chen，A.G.，Chen，Q.，et al.Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications［J］.Mol Psychiatry，2012，17（10）：1007－1016.
［43］Bhatt，D.H.，Zhang，S.and Gan，W.B.Dendritic spine dynamics［J］.Annu Rev Physiol，2009，71：261－282.
［44］Blot，K.，Bai，J.and Otani，S.The effect of non-competitive NMDA receptor antagonist MK-801 on neuronal activity in rodent prefrontal cortex：An animalmodel for cognitive symptoms of schizophrenia［J］.JPhysiol Paris，2013，107（6）：448－451.
［45］Benneyworth，M.A.，Roseman，A.S.，Basu，A.C.，et al.Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cellmarkers［J］.Neurosci Lett，2011，488（3）：267－271.
［46］Geddes，A.E.，Huang，X.F.and Newell，K.A.Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin-1 and their role in schizophrenia［J］.Prog Neuropsychopharmacol Biol Psychiatry，2011，35（4）：896－904.
［47］Enomoto，T.，Noda，Y.and Nabeshima，T.Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis［J］.Methods Find Exp Clin Pharmacol，2007，29（4）：291－301.
［48］Malhotra，A.K.，Pinals，D.A.，Adler，C.M.，et al.Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics［J］.Neuropsychopharmacology，1997，17（3）：141－150.
［49］Gilman，S.R.，Chang，J.，Xu，B.，et al.Diverse types of genetic variation converge on functional gene networks involved in schizophrenia［J］.Nat Neurosci，2012，15（12）：1723－1728.
［50］Hall，J.，Trent，S.，Thomas，K.L.，et al.Genetic risk for schizophrenia：Convergence on synaptic pathways involved in plasticity［J］.Biol Psychiatry，2015，77（1）：52－58.
［51］Hashimoto，T.，Arion，D.，Unger，T.，et al.Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjectswith schizophrenia［J］.Mol Psychiatry，2008，13（2）：147－161.
［52］Belforte，J.E.，Zsiros，V.，Sklar，E.R.，et al.Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes［J］.Nat Neurosci，2010，13（1）：76－83.
［53］Flames，N.，Long，J.E.，Garratt，A.N.，et al.Short-and long-range attraction of cortical GABAergic interneurons by neuregulin-1［J］.Neuron，2004，44（2）：251－261.
［54］Lewis，D.A.，Curley，A.A.，Glausier，J.R.，et al.Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia［J］.Trends Neurosci，2012，35（1）：57－67.
［55］Uchida，T.，Furukawa，T.，Iwata，S.，et al.Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygousmouse offspring［J］.Transl Psychiatry，2014，4：e371.
［56］Bale，T.L.，Baram，T.Z.，Brown，A.S.，et al.Early life programming and neurodevelopmental disorders［J］.Biol Psychiatry，2010，68（4）：314－319.
［57］Mcguffin，P.and Gottesman，I.I.Risk factors for schizophrenia［J］.The New England Journal of Medicine，1999，341（5）：370.
［58］Insel，T.R.Rethinking schizophrenia［J］.Nature，2010，468：187－193.
［59］Gottesman，I.I.Schizophrenia Genesis：The Origins of Madness［M］.New York：WH Freeman／Times Books／Henry Holt＆Co，1991.
［60］Brown，A.S.and Derkits，E.J.Prenatal infection and schizophrenia：A review of epidemiologic and translational studies［J］.Am JPsychiatry，2010，167（3）：261－280.
［61］Perrin，M.C.，Brown，A.S.and Malaspina，D.Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia［J］.Schizophrenia Bulletin，2007，33（6）：1270－1273.
［62］Susser，E.，Clair，D.S.，He，L.Latenteffects of prenatalmalnutrition on adulthealth［J］.Annals of the New York Academy of Sciences，2008，1136（1）：185－192.
［63］Kunugi，H.，Nanko，S.and Murray，R.M.Obstetric complications and schizophrenia：Prenatal underdevelopment and subsequent neurodevelopmental impairment［J］.The British Journal of Psychiatry，2001，178（S40）：s25－s29.
［64］Van Winkel，R.，Stefanis，N.C.and Myin-Germeys，I.Psychosocial stress and psychosis：A review of the neurobiological mechanisms and the evidence for genestress interaction［J］.Schizophrenia Bulletin，2008，34（6）：1095－1105.
［65］Kelly，B.D.，O'Callaghan，E.，Waddington，J.L.，et al.Schizophrenia and the city：A review of literature and prospective study of psychosis and urbanicity in Ireland［J］.Schizophrenia research，2010，116（1）：75－89.
［66］Cantor-Graae，E.and Selten，J.P.Schizophrenia and migration：A meta-analysis and review［J］.Am JPsychiatry，2005，162（1）：12－24.
［67］Davies，G.，Welham，J.，Chant，D.，et al.A systematic review andmeta-analysis of Northern Hemisphere season of birth studies in schizophrenia［J］.Schizophrenia Bulletin，2003，29（3）：587－593.
［68］Henquet，C.，Di Forti，M.，Morrison，P.，et al.Gene-environment interplay between cannabis and psychosis［J］.Schizophrenia Bulletin，2008，34（6）：1111－1121.
［69］Clarke，M.C.，Tanskanen，A.，Huttunen，M.，et al.Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia［J］.American Journal of Psychiatry，2009，166（9）：1025－1030.
［70］Samaco，R.C.and Neul，J.L.Complexities of Rett syndrome and MeCP2［J］.Journal of Neuroscience，2011，31（22）：7951－7959.
［71］Labrie，V.，Pai，S.and Petronis，A.Epigenetics of major psychosis：Progress，problems and perspectives［J］.Trends in Genetics，2012，28（9）：427－435.
［72］Dempster，E.L.，Pidsley，R.，Schalkwyk，L.C.，et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder［J］.Human Molecular Genetics，2011，20（24）：4786－4796.
［73］Rutten，B.P.and Mill，J.Epigeneticmediation of environmental influences inmajor psychotic disorders［J］.Schizophrenia Bulletin，2009，35（6）：1045－1056.
［74］Pidsley，R.，Dempster，E.，Troakes，C.，et al.Epigenetic and genetic variation at the IGF2／H19 imprinting control region on 11p15.5 is associated with cerebellum weight［J］.Epigenetics，2012，7（2）：155－163.
［75］Shi，J.，Levinson，D.F.，Duan，J.，et al.Common variants on chromosome 6p22.1 are associated with schizophrenia［J］.Nature，2009，460：753.
［76］Boks，M.P.，de Jong，N.M.，Kas，M.J.，et al.Current status and future prospects for epigenetic psychopharmacology［J］.Epigenetics，2012，7（1）：20－28.
［77］Pries，L.，Gülöksüz，S.，Kenis，G.DNAMethylation in Schizophrenia［M］.New York：Springer，2017.
［78］Dworkin，A.M.，Huang，T.H.and Toland，A.E.Epigenetic alterations in the breast：Implications for breast cancer detection，prognosis and treatment［J］.Semin Cancer Biol，2009，19（3）：165－171.
［79］Lo，P.K.and Sukumar，S.Epigenomics and breast cancer［J］.Pharmacogenomics，2008，9（12）：1879－1902.
［80］Wajed，S.A.，Laird，P.W.，Demeester，T.R.DNA methylation：An alternative pathway to cancer［J］.Ann Surg，2001，234（1）：10－20.
［81］Herceg，Z.and Vaissiere，T.Epigenetic mechanisms and cancer：An interface between the environment and the genome［J］.Epigenetics，2011，6（7）：804－819.
［82］Abdolmaleky，H.M.，Cheng，K.H.，Russo，A.，et al.Hypermethylation of the reelin（RELN）promoter in the brain of schizophrenic patients：A preliminary report［J］.Am JMed Genet B Neuropsychiatr Genet，2005，134B（1）：60－66.
［83］Abdolmaleky，H.M.，Cheng，K.H.，Faraone，S.V.，et al.Hypomethylation ofMBCOMT promoter is a major risk factor for schizophrenia and bipolar disorder［J］.Hum Mol Genet，2006，15（21）：3132－3145.
［84］Abdolmaleky，H.M.，Yaqubi，S.，Papageorgis，P.，et al.Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder［J］.Schizophr Res，2011，129（2－3）：183－190.
［85］Carrard，A.，Salzmann，A.，Malafosse，A.，et al.Increased DNAmethylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder［J］.JAffect Disord，2011，132（3）：450－453.
［86］Chen，Y.，Zhang，J.，Zhang，L.，et al.Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia［J］.Hum Genet，2012，131（7）：1081－1087.
［87］Dempster，E.L.，Mill，J.，Craig，I.W.，et al.The quantification of COMTmRNA in postmortem cerebellum tissue：Diagnosis，genotype，methylation and expression［J］.BMC Med Genet，2006，7：10.
［88］Dempster，E.L.，Pidsley，R.，Schalkwyk，L.C.，et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder［J］.Hum Mol Genet，2011，20（24）：4786－4796.
［89］Ghadirivasfi，M.，Nohesara，S.，Ahmadkhaniha，H.R.，et al.Hypomethylation of the serotonin receptor type-2A Gene（HTR2A）at T102C polymorphic site in DNA derived from the saliva of patientswith schizophrenia and bipolar disorder［J］.Am J Med Genet B Neuropsychiatr Genet，2011，156B（5）：536－545.
［90］Grayson，D.R.，Jia，X.，Chen，Y.，et al.Reelin promoter hypermethylation in schizophrenia［J］.Proc Natl Acad Sci USA，2005，102（26）：9341－9346.
［91］Iwamoto，K.，Bundo，M.，Yamada，K.，et al.DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia［J］.JNeurosci，2005，25（22）：5376－5381.
［92］Lott，S.A.，Burghardt，P.R.，Burghardt，K.J.，et al.The influence ofmetabolic syndrome，physical activity and genotype on catechol-O-methyl transferase promoterregion methylation in schizophrenia［J］.Pharmacogenomics J，2013，13（3）：264－271.
［93］Melas，P.A.，Rogdaki，M.，Osby，U.，et al.Epigenetic aberrations in leukocytes of patientswith schizophrenia：Association of global DNAmethylation with antipsychotic drug treatment and disease onset［J］.FASEB J，2012，26（6）：2712－2718.
［94］Mill，J.，Tang，T.，Kaminsky，Z.，et al.Epigenomic profiling reveals DNAmethylation changes associated with major psychosis［J］.Am JHum Genet，2008，82（3）：696－711.
［95］Nohesara，S.，Ghadirivasfi，M.，Mostafavi，S.，et al.DNA hypomethylation of MBCOMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder［J］.J Psychiatr Res，2011，45（11）：1432－1438.
［96］Petronis，A.，Gottesman，I.I.，Kan，P.，et al.Monozygotic twins exhibitnumerous epigenetic differences：Clues to twin discordance？［J］.Schizophr Bull，2003，29（1）：169－178.
［97］Tochigi，M.，Iwamoto，K.，Bundo，M.，et al.Methylation status of the reelin promoter region in the brain of schizophrenic patients［J］.Biol Psychiatry，2008，63（5）：530－533.
［98］Tolosa，A.，Sanjuan，J.，Dagnall，A.M.，et al.FOXP2 gene and language impairment in schizophrenia：Association and epigenetic studies［J］.BMC Med Genet，2010，11：114.
［99］Zhang，A.P.，Yu，J.，Liu，J.X.，et al.The DNA methylation profilewithin the 5′-regulatory region of DRD2 in discordant sib pairs with schizophrenia［J］.Schizophr Res，2007，90（1－3）：97－103.
［100］Thomas，E.A.Histone Posttranslational Modifications in Schizophrenia［M］.New York：Springer，2017.
［101］Mirnics，K.，Middleton，F.A.，Marquez，A.，et al.Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex［J］.Neuron，2000，28（1）：53－67.
［102］Sharma，R.P.，Rosen，C.，Kartan，S.，et al.Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder：Preliminary results from a clinical population［J］.Schizophr Res，2006，88（1－3）：227－231.
［103］Gavin，D.P.，Kartan，S.，Chase，K.，et al.Reduced baseline acetylated histone 3 levels，and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects［J］.Schizophr Res，2008，103（1－3）：330－332.
［104］Gavin，D.P.，Rosen，C.，Chase，K.，et al.Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures［J］.JPsychiatry Neurosci，2009，34（3）：232－237.
［105］Sharma，R.P.，Feiner，B.and Chase，K.A.Histone H3 phosphorylation is upregulated in PBMCs of schizophrenia patients in comparison to healthy controls［J］.Schizophr Res，2015，169（1－3）：498－499.
［106］Chase，K.A.，Rosen，C.，Rubin，L.H.，et al.Evidence of a sex-dependent restrictive epigenome in schizophrenia［J］.JPsychiatr Res，2015，65：87－94.
［107］Akbarian，S.，Ruehl，M.G.，Bliven，E.，et al.Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia［J］.Arch Gen Psychiatry，2005，62（8）：829－840.
［108］Chase，K.A.，Gavin，D.P.，Guidotti，A.，et al.Histone methylation at H3K9：Evidence for a restrictive epigenome in schizophrenia［J］.Schizophr Res，2013，149（1－3）：15－20.
［109］Huang，H.S.，Matevossian，A.，Whittle，C.，et al.Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters［J］.JNeurosci，2007，27（42）：11254－11262.
［110］Tang，B.，Dean，B.and Thomas，E.A.Disease-and age-related changes in histone acetylation at gene promoters in psychiatric disorders［J］.Transl Psychiatry，2011，1：e64.
［111］Kosower，N.S.，Gerad，L.，Goldstein，M.，et al.Constitutive heterochromatin of chromosome 1 and Duffy blood group alleles in schizophrenia［J］.Am J Med Genet，1995，60（2）：133－138.
［112］Zee，B.M.，Levin，R.S.，Xu，B.，et al.In vivo residue-specific histone methylation dynamics［J］.JBiol Chem，2010，285（5）：3341－3350.
［113］Tang，B.，Dean，B.，Thomas，E.A.Disease-and age-related changes in histone acetylation at gene promoters in psychiatric disorders［J］.Transl Psychiatry，2011，1：e64.
［114］Sharma，R.P.，Grayson，D.R.and Gavin，D.P.Histone deacylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects：Analysis of the National Brain Databank microarray collection［J］.Schizophr Res，2008，98（1－3）：111－117.
［115］Bartel，D.P.MicroRNAs：Genomics，biogenesis，mechanism，and function［J］.Cell，2004，116（2）：281.
［116］Nowak，J.S.and Michlewski，G.MiRNAs in development and pathogenesis of the nervous system［J］.Biochemical Society Transactions，2013，41（4）：815－820.
［117］Wang，J.，Wang，Y.，Yang，J.，et al.MicroRNAs as novel biomarkers of schizophrenia（Review）［J］.Experimental and Therapeutic Medicine，2014，8（6）：1671－1676.
［118］Miller，B.H.and Wahlestedt，C.MicroRNA dysregulation in psychiatric disease［J］.Brain Research，2010，1338：89－99.
［119］Sun，E.and Shi，Y.MicroRNAs：Smallmoleculeswith big roles in neurodevelopment and diseases［J］.Experimental Neurology，2015，268：46－53.
［120］Beveridge，N.J.and Cairns，M.J.MicroRNA dysregulation in schizophrenia［J］.Neurobiol Dis，2012，46（2）：263－271.
［121］Xu，Y.，Li，F.，Zhang，B.，et al.MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia［J］.Schizophrenia Research，2010，119（1－3）：219－227.
［122］Guo，A.，Sun，J.，Jia，P.，et al.A novel microRNA and transcription factor mediated regulatory network in schizophrenia［J］.BMC Systems Biology，2010，4（1）：10.
［123］Bravo，J.A.and Dinan，T.G.MicroRNAs：A novel therapeutic target for schizophrenia［J］.Curr Pharm Des，2011，17（2）：176－188.
［124］Mellios，N.，Huang，H.S.，Baker，S.P.，et al.Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia［J］.Biol Psychiatry，2009，65（12）：1006－1014.
［125］Ripke，S.，Sanders，A.R.，Kendler，K.S.，et al.Genome-wide association study identifies five new schizophrenia loci［J］.Nature Genetics，2011，43（10）：969－976.
［126］Hamshere，M.L.，Walters，J.T.R.，Smith，R.，et al.Genome-wide significant associations in schizophrenia to ITIH3／4，CACNA1C and SDCCAG8，and extensive replication of associations reported by the Schizophrenia PGC［J］.Molecular Psychiatry，2012，18（6）：708－712.
［127］Navarrete，K.，Pedroso，I.，De Jong，S.，et al.TCF4（e2-2；ITF2）：A schizophrenia-associated gene with pleiotropic effects on human disease［J］.Am J Med Genet B Neuropsychiatr Genet，2013，162B（1）：1－16.
［128］Kwon，E.，Wang，W.and Tsai，L.H.Validation of schizophrenia-associated genes CSMD1，C10orf26，CACNA1C and TCF4 asmiR-137 targets［J］.Mol Psychiatry，2013，18（1）：11－12.
［129］Kim，A.H.，Parker，E.K.，Williamson，V.，et al.Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137［J］.Schizophrenia Research，2012，141（1）：60－64.
［130］Valles，A.，Martens，G.J.，De Weerd，P.，et al.MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network：Implications for the etiology of schizophrenia［J］.JPsychiatry Neurosci，2014，39（5）：312－320.
［131］He，K.，An，Z.，Wang，Q.，et al.CACNA1C，schizophrenia and major depressive disorder in the Han Chinese population［J］.Br JPsychiatry，2014，204（1）：36－39.
［132］Guan，F.，Zhang，B.，Yan，T.，et al.MIR137 gene and targetgene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese［J］.Schizophrenia Research，2014，152（1）：97－104.
［133］Mueser，K.T.and Mcgurk，S.R.Schizophrenia［J］.The Lancet，2004，363：2063－2072.
［134］Vargas，G.Biomarkers in schizophrenia［J］.Biomarkers in Medicine，2014，8（1）：1－3.
［135］Kapur，S.，Phillips，A.G.and Insel，T.R.Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it？［J］.Molecular Psychiatry，2012，17（12）：1174－1179.
［136］First，M.B.Diagnostic and statisticalmanual ofmental disorders，5th edition，and clinical utility［J］.The Journal of Nervous and Mental Disease，2013，201（9）：727－729.
［137］Li，S.，Zhang，A.and Lin，H.Progress of GWAS and translationalmedicine for schizophrenia in China［J］.China Science：Life Science，2013，（1）：31－38.
［138］Santarelli，D.M.，Beveridge，N.J.，Tooney，P.A.，et al.Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex brodmann area 46 in schizophrenia［J］.Biological Psychiatry，2011，69（2）：180－187.
［139］Moreau，M.P.，Bruse，S.E.，David-Rus，R.，et al.Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder［J］.Biological Psychiatry，2011，69（2）：188－193.
［140］Mor，E.，Kano，S.，Colantuoni，C.，et al.MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients［J］.Neurobiology of Disease，2013，55：1－10.
［141］Gardiner，E.，Beveridge，N.J.，Wu，J.Q.，et al.Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells［J］.Molecular Psychiatry，2011，17（8）：827－840.
［142］Lai，C.，Yu，S.，Hsieh，M.H.，et al.MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia［J］.PLoS One，2011，6（6）：e21635.
［143］Shi，W.，Du，J.，Qi，Y.，et al.Aberrant expression of serum miRNAs in schizophrenia［J］.Journal of Psychiatric Research，2012，46（2）：198－204.
［144］Karayiorgou，M.，Simon，T.J.and Gogos，J.A.22q11.2 microdeletions：Linking DNA structural variation to brain dysfunction and schizophrenia［J］.Nature Reviews Neuroscience，2010，11（6）：402－416.
［145］de la Morena，M.T.，Eitson，J.L.，Dozmorov，I.M.，et al.Signature microRNA expression patterns identified in humans with 22q11.2 deletion／DiGeorge syndrome［J］.Clinical Immunology，2013，147（1）：11－22.
［146］Sun，X.，Lu，J.，Zhang，L.，et al.AberrantmicroRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients［J］.Journal of Clinical Neuroscience，2015，22（3）：570－574.
［147］Wei，H.，Yuan，Y.，Liu，S.，et al.Detection of circulating miRNA levels in schizophrenia［J］.Am JPsychiatry，2015，172（11）：1141－1147.
［148］Sun，X.Y.，Zhang，J.，Niu，W.，et al.A preliminary analysis ofmicroRNA as potential clinical biomarker for schizophrenia［J］.Am JMed Genet B Neuropsychiatr Genet，2015，168B（3）：170－178.
［149］Lai，C.Y.，Lee，S.Y.，Scarr，E.，et al.Aberrant expression of microRNAs as biomarker for schizophrenia：From acute state to partial remission，and from peripheral blood to cortical tissue［J］.Transl Psychiatry，2016，6：e717.
［150］Kalia，M.，Costa，E.and Silva，J.Biomarkers of psychiatric diseases：Current status and future prospects［J］.Metabolism，2015，64（3）：S11－S15.
［151］Schneider，A.and Simons，M.Exosomes：Vesicular carriers for intercellular communication in neurodegenerative disorders［J］.Cell Tissue Res，2013，352（1）：33－47.
［152］Tsilioni，I.，Panagiotidou，S.and Theoharides，T.C.Exosomes in neurologic and psychiatric disorders［J］.Clin Ther，2014，36（6）：882－888.
［153］Ng，S.Y.，Lin，L.，Soh，B.S.，et al.Long noncoding RNAs in development and disease of the central nervous system［J］.Trends Genet，2013，29（8）：461－468.
［154］Merelo，V.，Durand，D.，Lescallette，A.R.，et al.Associating schizophrenia，long non-coding RNAs and neurostructural dynamics［J］.FrontMol Neurosci，2015，8：57.
［155］Tomoda，T.，Sumitomo，A.，Jaaro-Peled，H.，et al.Utility and validity of DISC1 mousemodels in biological psychiatry［J］.Neuroscience，2016，321：99－107.
［156］Greenhill，S.D.，Juczewski，K.，de Haan，A.M.，et al.Neurodevelopment.Adult cortical plasticity depends on an early postnatal critical period［J］.Science，2015，349：424－427.(https://www.daowen.com)
［157］Soda，T.，Frank，C.，Ishizuka，K.，et al.DISC1-ATF4 transcriptional repression complex：Dual regulation of the cAMP-PDE4 cascade by DISC1［J］.Mol Psychiatry，2013，18（8）：898－908.
［158］Modarresi，F.，Faghihi，M.A.，Lopez-Toledano，M.A.，et al.Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation［J］.Nat Biotechnol，2012，30（5）：453－459.
［159］Favalli，G.，Li，J.，Belmonte-De-Abreu，P.，et al.The role of BDNF in the pathophysiology and treatment of schizophrenia［J］.J Psychiatr Res，2012，46（1）：1－11.
［160］Barry，G.，Briggs，J.A.，Vanichkina，D.P.，et al.The long noncoding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing［J］.Mol Psychiatry，2014，19（4）：486－494.
［161］Spadaro，P.A.，Flavell，C.R.，Widagdo，J.，et al.Long noncoding RNA-directed epigenetic regulation of gene expression is associated with anxiety-like behavior in mice［J］.Biol Psychiatry，2015，78（12）：848－859.
［162］Liao，Q.，Wang，Y.，Cheng，J.，et al.DNA methylation patterns of protein coding genes and long noncoding RNAs in female schizophrenic patients［J］.Eur JMed Genet，2015，58（2）：95－104.
［163］Ren，Y.，Cui，Y.，Li，X.，et al.A co-expression network analysis reveals lncRNA abnormalities in peripheral blood in early-onset schizophrenia［J］.Prog Neuropsychopharmacol Biol Psychiatry，2015，63：1－5.
［164］Dey，B.K.，Mueller，A.C.and Dutta，A.Long noncoding RNAs as emerging regulators of differentiation，development，and disease［J］.Transcription，2014，5（4）：e944014.
［165］Flint，J.and Munafo，M.Schizophrenia：Genesis of a complex disease［J］.Nature，2014，511：412－413.
［166］Ziats，M.N.and Rennert，O.M.Aberrant expression of long noncoding RNAs in autistic brain［J］.JMol Neurosci，2013，49（3）：589－593.
［167］Mohankumar，S.and Patel，T.Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer［J］.Brief FunctGenomics，2016，15（3）：249－256.
［168］Silva，A.，Bullock，M.and Calin，G.The clinical relevance of long noncoding RNAs in cancer［J］.Cancers（Basel），2015，7（4）：2169－2182.
［169］Cochetti，G.，Poli，G.，Guelfi，G.，et al.Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia：Evaluation of potential diagnostic and prognostic role［J］.Onco Targets Ther，2016，9：7545－7553.
［170］Sun，X.Y.，Lu，J.，Zhang，L.，et al.AberrantmicroRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients［J］.JClin Neurosci，2015，22（3）：570－574.
［171］Ma，J.，Shang，S.，Wang，J.，et al.Identification of miR-22-3p，miR-92a-3p，and miR-137 in peripheral blood as biomarker for schizophrenia［J］.Psychiatry Research，2018，265：70－76.
［172］Chen，S.，Sun，X.，Niu，W.，et al.Aberrant expression of long noncoding RNAs in schizophrenia patients［J］.Med Sci Monit，2016，22：3340－3351.
［173］Du Y，Yu，Y.，Hu，Y.，et al.Genome-wide，integrative analysis implicates exosome-derived microRNA dysregulation in schizophrenia［J］.Schizophr Bull，2019，45（6）：1257－1266.
［174］Rani，N.，Nowakowski，T.J.，Zhou，H.，et al.A primate lncRNA mediates notch signaling during neuronal developmentby sequesteringmiRNA［J］.Neuron，2016，90（6）：1174－1188.
［175］Raghavan，V.，Bhomia，M.，Torres，I.，et al.Hypothesis：ExosomalmicroRNAs as potential biomarkers for schizophrenia［J］.Med Hypotheses，2017，103：21－25.
［176］Deussing，J.M.and Jakovcevski，M.Histone Modifications in Major Depressive Disorder and Related Rodent Models［M］.New York：Springer，2017.
［177］Pishva，E.，Rutten，B.P.，van den Hove，D.DNAMethylation in Major Depressive Disorder［M］.New York：Springer，2017.
［178］Tsankova，N.M.，Kumar，A.and Nestler，E.J.Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures［J］.JNeurosci，2004，24（24）：5603－5610.
［179］Tsankova，N.M.，Berton，O.，Renthal，W.，et al.Sustained hippocampal chromatin regulation in amousemodelof depression and antidepressantaction［J］.Nat Neurosci，2006，9（4）：519－525.
［180］Fuchikami，M.，Morinobu，S.，Kurata，A.，et al.Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor（BDNF）gene and histone acetylation at its promoters in the rat hippocampus［J］.Int JNeuropsychopharmacol，2009，12（1）：73－82.
［181］Covington，H.R.，Maze，I.，Laplant，Q.C.，et al.Antidepressant actions of histone deacetylase inhibitors［J］.JNeurosci，2009，29（37）：11451－11460.
［182］Hinwood，M.，Tynan，R.J.，Day，T.A.，et al.Repeated social defeat selectively increases deltaFosB expression and histone H3 acetylation in the intralimbic medial prefrontal cortex［J］.Cereb Cortex，2011，21（2）：262－271.
［183］Montagud-Romero，S.，Montesinos，J.，Pascual，M.，et al.Up-regulation of histone acetylation induced by social defeat mediates the conditioned rewarding effects of cocaine［J］.Prog Neuropsychopharmacol Biol Psychiatry，2016，70：39－48.
［184］Kenworthy，C.A.，Sengupta，A.，Luz，S.M.，et al.Social defeat induces changes in histone acetylation and expression of histone modifying enzymes in the ventral hippocampus，prefrontal cortex，and dorsal raphe nucleus［J］.Neuroscience，2014，264：88－98.
［185］Uchida，S.，Hara，K.，Kobayashi，A.，et al.Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events［J］.Neuron，2011，69（2）：359－372.
［186］Abe-Higuchi，N.，Uchida，S.，Yamagata，H.，et al.Hippocampal sirtuin 1 signaling mediates depression-like behavior［J］.Biol Psychiatry，2016，80（11）：815－826.
［187］Jiang，W.G.，Li，S.X.，Liu，J.F.，et al.Hippocampal CLOCK protein participates in the persistence of depressive-like behavior induced by chronic unpredictable stress［J］.Psychopharmacology（Berl），2013，227（1）：79－92.
［188］Jiang，Y.，Jakovcevski，M.，Bharadwaj，R.，et al.Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B［J］.JNeurosci，2010，30（21）：7152－7167.
［189］Wei，J.，Xiong，Z.，Lee，J.B.，et al.Histone modification of Nedd4 ubiquitin ligase controls the loss of AMPA receptors and cognitive impairment induced by repeated stress［J］.JNeurosci，2016，36（7）：2119－2130.
［190］Covington，H.R.，Maze，I.，Sun，H.，et al.A role for repressive histone methylation in cocaine-induced vulnerability to stress［J］.Neuron，2011，71（4）：656－670.
［191］Robison，A.J.，Vialou，V.，Sun，H.S.，et al.Fluoxetine epigenetically alters the CaMKIIalpha promoter in nucleus accumbens to regulate DeltaFosB binding and antidepressant effects［J］.Neuropsychopharmacology，2014，39（5）：1178－1186.
［192］Golden，S.A.，Christoffel，D.J.，Heshmati，M.，et al.Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression［J］.Nat Med，2013，19（3）：337－344.
［193］Cruceanu，C.，Alda，M.，Nagy，C.，et al.H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression［J］.Int JNeuropsychopharmacol，2013，16（2）：289－299.
［194］Chen，E.S.，Ernst，C.and Turecki，G.The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression［J］.Int JNeuropsychopharmacol，2011，14（3）：427－429.
［195］Hobara，T.，Uchida，S.，Otsuki，K.，et al.Altered gene expression of histone deacetylases inmood disorder patients［J］.JPsychiatr Res，2010，44（5）：263－270.
［196］Del，R.P.and Trievel，R.C.Substrate and product specificities of SET domain methyltransferases［J］.Epigenetics，2011，6（9）：1059－1067.
［197］Shen，E.Y.，Jiang，Y.，Javidfar，B.，et al.Neuronal deletion of Kmt2a／Mll1 histone methyltransferase in ventral striatum is associated with defective spiketiming-dependent striatal synaptic plasticity，altered response to dopaminergic drugs，and increased anxiety［J］.Neuropsychopharmacology，2016，41（13）：3103－3113.
［198］Weaver，I.C.，Meaney，M.J.and Szyf，M.Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood［J］.Proc Natl Acad SciUSA，2006，103（9）：3480－3485.
［199］Han，A.，Sung，Y.B.，Chung，S.Y.，et al.Possible additional antidepressant-like mechanism of sodium butyrate：Targeting the hippocampus［J］.Neuropharmacology，2014，81：292－302.
［200］Schroeder，F.A.，Lin，C.L.，Crusio，W.E.，et al.Antidepressant-like effects of the histone deacetylase inhibitor，sodium butyrate，in the mouse［J］.Biol Psychiatry，2007，62（1）：55－64.
［201］Schmauss，C.An HDAC-dependent epigenetic mechanism that enhances the efficacy of the antidepressant drug fluoxetine［J］.Sci Rep，2015，5：8171.
［202］Fuchikami，M.，Yamamoto，S.，Morinobu，S.，et al.The potential use of histone deacetylase inhibitors in the treatmentof depression［J］.Prog Neuropsychopharmacol Biol Psychiatry，2016，64：320－324.
［203］Dias，C.，Feng，J.，Sun，H.，et al.Beta-cateninmediates stress resilience through dicer1／microRNA regulation［J］.Nature，2014，516：51－55.
［204］Bagot，R.C.，Cates，H.M.，Purushothaman，I.，et al.Circuit-wide transcriptional profiling reveals brain region-specific gene networks regulating depression susceptibility［J］.Neuron，2016，90（5）：969－983.
［205］Rada-Iglesias，A.，Bajpai，R.，Swigut，T.，et al.A unique chromatin signature uncovers early developmentalenhancers in humans［J］.Nature，2011，470：279－283.
［206］Macdonald，J.L.and Roskams，A.J.Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development［J］.Dev Dyn，2008，237（8）：2256－2267.
［207］Shulha，H.P.，Cheung，I.，Whittle，C.，et al.Epigenetic signatures of autism：Trimethylated H3K4 landscapes in prefrontal neurons［J］.Arch Gen Psychiatry，2012，69（3）：314－324.
［208］Heinz，S.，Romanoski，C.E.，Benner，C.，et al.The selection and function of cell type-specific enhancers［J］.Nat Rev Mol Cell Biol，2015，16（3）：144－154.
［209］Jakovcevski，M.，Akbarian，S.and Di Benedetto，B.Pharmacologicalmodulation of astrocytes and the role of cell type-specific histonemodifications for the treatment of mood disorders［J］.Curr Opin Pharmacol，2016，26：61－66.
［210］Lima，A.，Sardinha，V.M.，Oliveira，A.F.，et al.Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats［J］.Mol Psychiatry，2014，19（7）：834－841.
［211］Mayhew，J.，Beart，P.M.and Walker，F.R.Astrocyte and microglial control of glutamatergic signalling：A primer on understanding the disruptive role of chronic stress［J］.JNeuroendocrinol，2015，27（6）：498－506.
［212］Sanacora，G.and Banasr，M.From pathophysiology to novel antidepressant drugs：Glial contributions to the pathology and treatment of mood disorders［J］.Biol Psychiatry，2013，73（12）：1172－1179.
［213］Bessa，J.M.，Morais，M.，Marques，F.，et al.Stress-induced anhedonia is associated with hypertrophy of medium spiny neurons of the nucleus accumbens［J］.Transl Psychiatry，2013，3：e266.
［214］Jakovcevski，M.，Ruan，H.，Shen，E.Y.，et al.Neuronal Kmt2a／Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory［J］.JNeurosci，2015，35（13）：5097－5108.
［215］Zhang，Y.，Chen，K.，Sloan，S.A.，et al.An RNA-sequencing transcriptome and splicing database of glia，neurons，and vascular cells of the cerebral cortex［J］.J Neurosci，2014，34（36）：11929－11947.
［216］Gerfen，C.R.，Paletzki，R.and Heintz，N.GENSAT BAC cre-recombinase driver lines to study the functional organization of cerebral cortical and basal ganglia circuits［J］.Neuron，2013，80（6）：1368－1383.
［217］Sanz，E.，Yang，L.，Su，T.，et al.Cell-type-specific isolation of ribosomeassociated mRNA from complex tissues［J］.Proc Natl Acad Sci USA，2009，106（33）：13939－13944.
［218］Zeisel，A.，Munoz-Manchado，A.B.，Codeluppi，S.，et al.Brain structure.Cell types in themouse cortex and hippocampus revealed by single-cell RNA-seq［J］.Science，2015，347：1138－1142.
［219］Falahi，F.，Huisman，C.，Kazemier，H.G.，et al.Towards sustained silencing of HER2／neu in cancer by epigenetic editing［J］.Mol Cancer Res，2013，11（9）：1029－1039.
［220］Hilton，I.B.，D'Ippolito，A.M.，Vockley，C.M.，et al.Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers［J］.Nat Biotechnol，2015，33（5）：510－517.
［221］Mendenhall，E.M.，Williamson，K.E.，Reyon，D.，et al.Locus-specific editing of histone modifications at endogenous enhancers［J］.Nat Biotechnol，2013，31（12）：1133－1136.
［222］Heller，E.A.，Hamilton，P.J.，Burek，D.D.，et al.Targeted epigenetic remodeling of the Cdk5 gene in nucleus accumbens regulates cocaine-and stressevoked behavior［J］.JNeurosci，2016，36（17）：4690－4697.
［223］Heller，E.A.，Cates，H.M.，Pena，C.J.，et al.Locus-specific epigenetic remodeling controls addiction-and depression-related behaviors［J］.Nat Neurosci，2014，17（12）：1720－1727.
［224］Mcgowan，P.O.，Sasaki，A.，D'Alessio，A.C.，et al.Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse［J］.Nat Neurosci，2009，12（3）：342－348.
［225］Weaver，I.C.，Cervoni，N.，Champagne，F.A.，et al.Epigenetic programming by maternal behavior［J］.Nat Neurosci，2004，7（8）：847－854.
［226］Oberlander，T.F.，Weinberg，J.，Papsdorf，M.，et al.Prenatal exposure tomaternal depression，neonatalmethylation of human glucocorticoid receptor gene（NR3C1）and infant cortisol stress responses［J］.Epigenetics，2008，3（2）：97－106.
［227］Palma-Gudiel，H.，Cordova-Palomera，A.，Eixarch，E.，et al.Maternal psychosocial stress during pregnancy alters the epigenetic signature of the glucocorticoid receptor gene promoter in their offspring：A meta-analysis［J］.Epigenetics，2015，10（10）：893－902.
［228］Tyrka，A.R.，Parade，S.H.，Welch，E.S.，et al.Methylation of the leukocyte glucocorticoid receptor gene promoter in adults：Associations with early adversity and depressive，anxiety and substance-use disorders［J］.Transl Psychiatry，2016，6（7）：e848.
［229］Denny，W.B.，Valentine，D.L.，Reynolds，P.D.，et al.Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding［J］.Endocrinology，2000，141（11）：4107－4113.
［230］Binder，E.B.The role of FKBP5，a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders［J］.Psychoneuroendocrinology，2009，34 Suppl 1：S186－S195.
［231］Zannas，A.S.and Binder，E.B.Gene-environment interactions at the FKBP5 locus：Sensitive periods，mechanisms and pleiotropism［J］.Genes Brain Behav，2014，13（1）：25－37.
［232］Klengel，T.and Binder，E.B.Gene x environment interactions in the prediction of response to antidepressant treatment［J］.Int J Neuropsychopharmacol，2013，16（3）：701－711.
［233］Duman，R.S.Role of neurotrophic factors in the etiology and treatment of mood disorders［J］.Neuromolecular Med，2004，5（1）：11－25.
［234］Pan，W.，Banks，W.A.，Fasold，M.B.，et al.Transport of brain-derived neurotrophic factor across the blood-brain barrier［J］.Neuropharmacology，1998，37（12）：1553－1561.
［235］Lee，B.H.and Kim，Y.K.The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment［J］.Psychiatry Investig，2010，7（4）：231－235.
［236］Boulle，F.，van den Hove，D.L.，Jakob，S.B.，et al.Epigenetic regulation of the BDNF gene：Implications for psychiatric disorders［J］.Mol Psychiatry，2012，17（6）：584－596.
［237］Januar，V.，Ancelin，M.L.，Ritchie，K.，et al.BDNF promoter methylation and genetic variation in late-life depression［J］.Transl Psychiatry，2015，5：e619.
［238］Keller，S.，Sarchiapone，M.，Zarrilli，F.，et al.Increased BDNF promoter methylation in the Wernicke area of suicide subjects［J］.Arch Gen Psychiatry，2010，67（3）：258－267.
［239］Fuchikami，M.，Morinobu，S.，Segawa，M.，et al.DNA methylation profiles of the brain-derived neurotrophic factor（BDNF）gene as a potent diagnostic biomarker in major depression［J］.PLoSOne，2011，6（8）：e23881.
［240］Na，K.S.，Won，E.，Kang，J.，et al.Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrentmajor depressive disorder［J］.Sci Rep，2016，6：21089.
［241］Choi，S.，Han，K.M.，Won，E.，et al.Association of brain-derived neurotrophic factor DNA methylation and reduced white matter integrity in the anterior corona radiata inmajor depression［J］.JAffect Disord，2015，172：74－80.
［242］Kang，H.J.，Kim，J.M.，Lee，J.Y.，et al.BDNF promotermethylation and suicidal behavior in depressive patients［J］.JAffect Disord，2013，151（2）：679－685.
［243］Kang，H.J.，Kim，J.M.，Bae，K.Y.，et al.Longitudinal associations between BDNF promotermethylation and late-life depression［J］.Neurobiol Aging，2015，36（4）：1761－1764.
［244］Kang，H.J.，Kim，J.M.，Kim，S.Y.，et al.A longitudinal study of BDNF promoter methylation and depression in breast cancer［J］.Psychiatry Investig，2015，12（4）：523－531.
［245］Kleimann，A.，Kotsiari，A.，Sperling，W.，et al.BDNF serum levels and promoter methylation of BDNF exon I，IV and VI in depressed patients receiving electroconvulsive therapy［J］.JNeural Transm（Vienna），2015，122（6）：925－928.
［246］Tadic，A.，Muller-Engling，L.，Schlicht，K.F.，et al.Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression［J］.Mol Psychiatry，2014，19（3）：281－283.
［247］Owens，M.J.and Nemeroff，C.B.Role of serotonin in the pathophysiology of depression：Focus on the serotonin transporter［J］.Clin Chem，1994，40（2）：288－295.
［248］Caspi，A.，Sugden，K.，Moffitt，T.E.，et al.Influence of life stress on depression：Moderation by a polymorphism in the 5-HTT gene［J］.Science，2003，301：386－389.
［249］Philibert，R.A.，Sandhu，H.，Hollenbeck，N.，et al.The relationship of 5HTT（SLC6A4）methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies［J］.Am JMed Genet B Neuropsychiatr Genet，2008，147B（5）：543－549.
［250］Olsson，C.A.，Foley，D.L.，Parkinson-Bates，M.，et al.Prospects for epigenetic research within cohort studies of psychological disorder：A pilot investigation of a peripheral cellmarker of epigenetic risk for depression［J］.Biol Psychol，2010，83（2）：159－165.
［251］Kang，H.J.，Kim，J.M.，Stewart，R.，et al.Association of SLC6A4 methylation with early adversity，characteristics and outcomes in depression［J］.Prog Neuropsychopharmacol Biol Psychiatry，2013，44：23－28.
［252］Domschke，K.，Tidow，N.，Schwarte，K.，et al.Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response［J］.Int J Neuropsychopharmacol，2014，17（8）：1167－1176.
［253］Wang，D.，Szyf，M.，Benkelfat，C.，et al.Peripheral SLC6A4 DNAmethylation is associated with in vivomeasures of human brain serotonin synthesis and childhood physical aggression［J］.PLoSOne，2012，7（6）：e39501.
［254］Dannlowski，U.，Kugel，H.，Redlich，R.，et al.Serotonin transporter gene methylation is associated with hippocampal gray matter volume［J］.Hum Brain Mapp，2014，35（11）：5356－5367.
［255］Booij，L.，Szyf，M.，Carballedo，A.，et al.DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume：A study in depressed patients and healthy controls［J］.PLoSOne，2015，10（3）：e119061.
［256］Sabunciyan，S.，Aryee，M.J.，Irizarry，R.A.，et al.Genome-wide DNA methylation scan in major depressive disorder［J］.PLoS One，2012，7（4）：e34451.
［257］Nagy，C.，Suderman，M.，Yang，J.，et al.Astrocytic abnormalities and global DNA methylation patterns in depression and suicide［J］.Mol Psychiatry，2015，20（3）：320－328.
［258］Uddin，M.，Koenen，K.C.，Aiello，A.E.，et al.Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample［J］.Psychol Med，2011，41（5）：997－1007.
［259］Numata，S.，Ishii，K.，Tajima，A.，et al.Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles：Discovery and validation［J］.Epigenetics，2015，10（2）：135－141.
［260］Weder，N.，Zhang，H.，Jensen，K.，et al.Child abuse，depression，and methylation in genes involved with stress，neural plasticity，and brain circuitry［J］.JAm Acad Child Adolesc Psychiatry，2014，53（4）：417－424.
［261］Murphy，T.M.，Crawford，B.，Dempster，E.L.，et al.Methylomic profiling of cortex samples from completed suicide cases implicates a role for PSORS1C3 in major depression and suicide［J］.Transl Psychiatry，2017，7（1）：e989.
［262］Dempster，E.L.，Wong，C.C.，Lester，K.J.，et al.Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression［J］.Biol Psychiatry，2014，76（12）：977－983.
［263］Cordova-Palomera，A.，Fatjo-Vilas，M.，Gasto，C.，et al.Genome-wide methylation study on depression：Differentialmethylation and variable methylation in monozygotic twins［J］.Transl Psychiatry，2015，5：e557.
［264］Davies，M.N.，Krause，L.，Bell，J.T.，et al.Hypermethylation in the ZBTB20 gene is associated with major depressive disorder［J］.Genome Biol，2014，15（4）：R56.
［265］Oh，G.，Wang，S.C.，Pal，M.，et al.DNAmodification study ofmajor depressive disorder：Beyond locus-by-locus comparisons［J］.Biol Psychiatry，2015，77（3）：246－255.
［266］Zimmermann，N.，Zschocke，J.，Perisic，T.，et al.Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels［J］.Biochem J，2012，448（1）：93－102.
［267］Detich，N.，Bovenzi，V.，Szyf，M.Valproate induces replication-independent active DNA demethylation［J］.JBiol Chem，2003，278（30）：27586－27592.
［268］Schroeder，J.W.，Smith，A.K.，Brennan，P.A.，et al.DNA methylation in neonates born to women receiving psychiatric care［J］.Epigenetics，2012，7（4）：409－414.
［269］Gurnot，C.，Martin-Subero，I.，Mah，S.M.，et al.Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates［J］.Epigenetics，2015，10（5）：361－372.
［270］Zhao，J.，Goldberg，J.，Bremner，J.D.，et al.Association between promoter methylation of serotonin transporter gene and depressive symptoms：A monozygotic twin study［J］.Psychosom Med，2013，75（6）：523－529.
［271］Lin，R.and Turecki，G.Noncoding RNAs in Depression［M］.New York：Springer，2017，197－210.
［272］World Health Organization.Depression 2016［Z／OL］.http：／／www.who.int／mediacentre／factsheets／fs369／en／.
［273］American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders（5th ed.）［M］.Washington，DC：APA，2013.
［274］Sullivan，P.F.，de Geus，E.J.，Willemsen，G.，et al.Genome-wide association formajor depressive disorder：A possible role for the presynaptic protein piccolo［J］.Mol Psychiatry，2009，14（4）：359－375.
［275］Sullivan，P.F.，Neale，M.C.and Kendler，K.S.Genetic epidemiology ofmajor depression：Review and meta-analysis［J］.Am J Psychiatry，2000，157（10）：1552－1562.
［276］Lewis，C.M.，Ng，M.Y.，Butler，A.W.，et al.Genome-wide association study of major recurrent depression in the U.K.population［J］.Am J Psychiatry，2010，167（8）：949－957.
［277］Muglia，P.，Tozzi，F.，Galwey，N.W.，et al.Genome-wide association study of recurrentmajor depressive disorder in two European case-control cohorts［J］.Mol Psychiatry，2010，15（6）：589－601.
［278］Rietschel，M.，Mattheisen，M.，Frank，J.，et al.Genome-wide association-，replication-，and neuroimaging study implicates HOMER1 in the etiology ofmajor depression［J］.Biol Psychiatry，2010，68（6）：578－585.
［279］Shi，J.，Potash，J.B.，Knowles，J.A.，et al.Genome-wide association study of recurrent early-onset major depressive disorder［J］.Mol Psychiatry，2011，16（2）：193－201.
［280］Fernandez-Pujals，A.M.，Adams，M.J.，Thomson，P.，et al.Epidemiology and heritability ofmajor depressive disorder，stratified by age of onset，sex，and illness course in generation Scotland：Scottish Family Health Study（GS：SFHS）［J］.PLoSOne，2015，10（11）：e142197.
［281］Clark，M.B.，Amaral，P.P.，Schlesinger，F.J.，et al.The reality of pervasive transcription［J］.PLoSBiol，2011，9（7）：e1000625，e1001102.
［282］Pauli，A.，Rinn，J.L.and Schier，A.F.Non-coding RNAs as regulators of embryogenesis［J］.Nat Rev Genet，2011，12（2）：136－149.
［283］Hardt，J.，Bernert，S.，Matschinger，H.，et al.Suicidality and its relationship with depression，alcohol disorders and childhood experiences of violence：Results from the ESEMeD study［J］.JAffect Disord，2015，175：168－174.
［284］Guo，H.，Ingolia，N.T.，Weissman，J.S.，et al.Mammalian microRNAs predominantly act to decrease targetmRNA levels［J］.Nature，2010，466：835－840.
［285］Baudry，A.，Mouillet-Richard，S.，Schneider，B.，et al.MiR-16 targets the serotonin transporter：A new facet for adaptive responses to antidepressants［J］.Science，2010，329（5998）：1537－1541.
［286］Song，M.F.，Dong，J.Z.，Wang，Y.W.，et al.CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system［J］.JAffect Disord，2015，178：25－31.
［287］Issler，O.，Haramati，S.，Paul，E.D.，et al.MicroRNA 135 is essential for chronic stress resiliency，antidepressant efficacy，and intact serotonergic activity［J］.Neuron，2014，83（2）：344－360.
［288］He，M.，Yan，H.，Duan，Z.X.，et al.Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population［J］.Int JClin Exp Pathol，2013，6（6）：1142－1149.
［289］Dunlop，B.W.and Nemeroff，C.B.The role of dopamine in the pathophysiology of depression［J］.Arch Gen Psychiatry，2007，64（3）：327－337.
［290］Zhang，Y.，Wang，Y.，Wang，L.，et al.Dopamine receptor D2 and associated microRNAs are involved in stress susceptibility and resistance to escitalopram treatment［J］.Int JNeuropsychopharmacol，2015，18（8）：ii.
［291］Gross，J.A.and Turecki，G.Suicide and the polyamine system［J］.CNSNeurol Disord Drug Targets，2013，12（7）：980－988.
［292］Fiori，L.M.and Turecki，G.Implication of the polyamine system in mental disorders［J］.JPsychiatry Neurosci，2008，33（2）：102－110.
［293］Turecki，G.The molecular bases of the suicidal brain［J］.Nat Rev Neurosci，2014，15（12）：802－816.
［294］Fiori，L.M.，Wanner，B.，Jomphe，V.，et al.Association of polyaminergic loci with anxiety，mood disorders，and attempted suicide［J］.PLoS One，2010，5（11）：e15146.
［295］Sequeira，A.，Gwadry，F.G.，Ffrench-Mullen，J.M.，et al.Implication of SSAT by gene expression and genetic variation in suicide and major depression［J］.Arch Gen Psychiatry，2006，63（1）：35－48.
［296］Fiori，L.M.，Bureau，A.，Labbe，A.，et al.Global gene expression profiling of the polyamine system in suicide completers［J］.Int J Neuropsychopharmacol，2011，14（5）：595－605.
［297］Klempan，T.A.，Rujescu，D.，Merette，C.，et al.Profiling brain expression of the spermidine／spermine N1-acetyltransferase 1（SAT1）gene in suicide［J］.Am J Med Genet B Neuropsychiatr Genet，2009，150B（7）：934－943.
［298］Chen，G.G.，Fiori，L.M.，Moquin，L.，et al.Evidence of altered polyamine concentrations in cerebral cortex of suicide completers［J］.Neuropsychopharmacology，2010，35（7）：1477－1484.
［299］Lopez，J.P.，Fiori，L.M.，Gross，J.A.，et al.Regulatory role of miRNAs in polyamine gene expression in the prefrontal cortex of depressed suicide completers［J］.Int JNeuropsychopharmacol，2014，17（1）：23－32.
［300］Lopez，J.P.，Lim，R.，Cruceanu，C.，et al.MiR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment［J］.Nat Med，2014，20（7）：764－768.
［301］Pilc，A.，Chaki，S.，Nowak，G.，et al.Mood disorders：Regulation bymetabotropic glutamate receptors［J］.Biochem Pharmacol，2008，75（5）：997－1006.
［302］Davis，M.J.，Iancu，O.D.，Acher，F.C.，et al.Role ofmGluR4 in acquisition of fear learning and memory［J］.Neuropharmacology，2013，66：365－372.
［303］Li，J.，Meng，H.，Cao，W.，et al.MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4［J］.Neurosci Lett，2015，606：167－172.
［304］Smalheiser，N.R.，Lugli，G.，Rizavi，H.S.，et al.MicroRNA expression is downregulated and reorganized in prefrontal cortex of depressed suicide subjects［J］.PLoSOne，2012，7（3）：e33201.
［305］Tseng，P.T.，Cheng，Y.S.，Chen，Y.W.，et al.Increased levels of vascular endothelial growth factor in patientswithmajor depressive disorder：A meta-analysis［J］.Eur Neuropsychopharmacol，2015，25（10）：1622－1630.
［306］Dwivedi，Y.Pathogenetic and therapeutic applications of microRNAs in major depressive disorder［J］.Prog Neuropsychopharmacol Biol Psychiatry，2016，64：341－348.
［307］Smalheiser，N.R.，Lugli，G.，Zhang，H.，et al.Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia，bipolar disorder and depressed subjects［J］.PLoSOne，2014，9（1）：e86469.
［308］Maffioletti，E.，Cattaneo，A.，Rosso，G.，et al.Peripheralwhole bloodmicroRNA alterations in major depression and bipolar disorder［J］.J Affect Disord，2016，200：250－258.
［309］Belzeaux，R.，Bergon，A.，Jeanjean，V.，et al.Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode［J］.Transl Psychiatry，2012，2：e185.
［310］Bratkovic，T.and Rogelj，B.Biology and applications of small nucleolar RNAs［J］.Cell Mol Life Sci，2011，68（23）：3843－3851.
［311］Fan，H.M.，Sun，X.Y.，Guo，W.，et al.Differential expression ofmicroRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients［J］.JPsychiatr Res，2014，59：45－52.